{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:57:52Z","timestamp":1781326672571,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007547","name":"Air Force Medical University","doi-asserted-by":"publisher","award":["2024XJSY44"],"award-info":[{"award-number":["2024XJSY44"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon: X"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.toxcx.2026.100255","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:32:33Z","timestamp":1775579553000},"page":"100255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Qiaozhen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqiu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"34","key":"10.1016\/j.toxcx.2026.100255_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000010659","article-title":"Clinical analysis of 86 botulism cases caused by cosmetic injection of botulinum toxin (BoNT)","volume":"97","author":"Bai","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.toxcx.2026.100255_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113767","article-title":"Ischemic stroke-induced polyaxonal innervation at the neuromuscular junction is attenuated by robot-assisted mechanical therapy","volume":"343","author":"Balch","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.toxcx.2026.100255_bib3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cpr.2016.01.003","article-title":"Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): a systematic review","volume":"45","author":"Brown","year":"2016","journal-title":"Clin. Psychol. Rev."},{"issue":"3","key":"10.1016\/j.toxcx.2026.100255_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00702-021-02312-4","article-title":"Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity","volume":"128","author":"Dressler","year":"2021","journal-title":"J. Neural Transm."},{"issue":"4","key":"10.1016\/j.toxcx.2026.100255_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/toxins16040184","article-title":"The role of botulinum toxin type-A in spasticity: research trends from a bibliometric analysis","volume":"16","author":"Facciorusso","year":"2024","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxcx.2026.100255_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/ene.13813","article-title":"Stroke-related epilepsy","volume":"26","author":"Feyissa","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.toxcx.2026.100255_bib7","doi-asserted-by":"crossref","DOI":"10.2340\/16501977-2753","article-title":"A practical guide to optimizing the benefits of post-stroke spasticity interventions with botulinum toxin A: an international group consensus","volume":"53","author":"Francisco","year":"2021","journal-title":"J. Rehabil. Med."},{"issue":"2","key":"10.1016\/j.toxcx.2026.100255_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1474-4422(17)30404-0","article-title":"Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study","volume":"17","author":"Galovic","year":"2018","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.toxcx.2026.100255_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/s12877-022-03120-5","article-title":"Association of cognitive enhancers and incident seizure risk in dementia: a population-based study","volume":"22","author":"Ha","year":"2022","journal-title":"BMC Geriatr."},{"issue":"4","key":"10.1016\/j.toxcx.2026.100255_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/ana.24605","article-title":"Botulinum toxin type A for neuropathic pain in patients with spinal cord injury","volume":"79","author":"Han","year":"2016","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.toxcx.2026.100255_bib11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1212\/WNL.0000000000000183","article-title":"Mood, anxiety, and incomplete seizure control affect quality of life after epilepsy surgery","volume":"82","author":"Hamid","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.toxcx.2026.100255_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"issue":"6","key":"10.1016\/j.toxcx.2026.100255_bib13","article-title":"Uses and technique of ultrasound-guided botulinum toxin infiltration","volume":"67","author":"Llorente Peris","year":"2025","journal-title":"Radiologia (Engl Ed)."},{"issue":"2","key":"10.1016\/j.toxcx.2026.100255_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"10","key":"10.1016\/j.toxcx.2026.100255_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2174\/1389557520666200228105312","article-title":"Botulinum toxin as a biological warfare agent: poisoning, diagnosis and countermeasures","volume":"20","author":"Pohanka","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"issue":"Suppl. l_1","key":"10.1016\/j.toxcx.2026.100255_bib16","first-page":"S4","article-title":"Clinical characteristics and ancillary test results among patients with botulism-united states, 2002-2015","volume":"66","author":"Rao","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.toxcx.2026.100255_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7002a1","article-title":"Clinical guidelines for diagnosis and treatment of botulism","volume":"70","author":"Rao","year":"2021","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"issue":"19","key":"10.1016\/j.toxcx.2026.100255_bib18","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development subcommittee of the American academy of neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"},{"issue":"52","key":"10.1016\/j.toxcx.2026.100255_bib19","doi-asserted-by":"crossref","first-page":"14147","DOI":"10.1523\/JNEUROSCI.4248-08.2008","article-title":"Increasing human brain excitability by transcranial high-frequency random noise stimulation","volume":"28","author":"Terney","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxcx.2026.100255_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fbioe.2018.00080","article-title":"Botulinum neurotoxin detection methods for public health response and surveillance","volume":"6","author":"Thirunavukkarasu","year":"2018","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"9","key":"10.1016\/j.toxcx.2026.100255_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3390\/toxins15090541","article-title":"Is botulinum toxin effective in treating orofacial neuropathic pain disorders? A systematic review","volume":"15","author":"Val","year":"2023","journal-title":"Toxins"},{"issue":"1","key":"10.1016\/j.toxcx.2026.100255_bib23","first-page":"15","article-title":"Botulinum toxin for painful spasms from focal seizures: theoretical considerations and case report","volume":"19","author":"Wilkenfeld","year":"2013","journal-title":"Neurol."}],"container-title":["Toxicon: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590171026000147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590171026000147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:39:18Z","timestamp":1781325558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590171026000147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"alternative-id":["S2590171026000147"],"URL":"https:\/\/doi.org\/10.1016\/j.toxcx.2026.100255","relation":{},"ISSN":["2590-1710"],"issn-type":[{"value":"2590-1710","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis","name":"articletitle","label":"Article Title"},{"value":"Toxicon: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxcx.2026.100255","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100255"}}